메뉴 건너뛰기




Volumn 5, Issue 1, 2013, Pages

Beta thalassemia major in a developing country: Epidemiological, clinical and evolutionary aspects

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BENZATHINE PENICILLIN; CHELATING AGENT; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN; PENICILLIN DERIVATIVE;

EID: 84877954331     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2013.002     Document Type: Article
Times cited : (17)

References (34)
  • 1
    • 84867750417 scopus 로고    scopus 로고
    • Evolution of Hemoglobinopathy Prevention in Africa: Results Problems and Prospect
    • Fattoum S. Evolution of Hemoglobinopathy Prevention in Africa: Results, Problems and Prospect. Mediterr J Hematol Infect Dis. 2009;1:e2009005
    • (2009) Mediterr J Hematol Infect Dis , vol.1
    • Fattoum, S.1
  • 3
    • 0034669984 scopus 로고    scopus 로고
    • Alloimmunization and erythrocyte autoimmunization in transfusion dependant thalassemia patients of predominantly Asian descent
    • Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion dependant thalassemia patients of predominantly Asian descent. Blood 2000;96:3369-3373
    • (2000) Blood , vol.96 , pp. 3369-3373
    • Singer, S.T.1    Wu, V.2    Mignacca, R.3    Kuypers, F.A.4    Morel, P.5    Vichinsky, E.P.6
  • 4
    • 0029942003 scopus 로고    scopus 로고
    • The risk of transfusion-transmitted viral infections The retrovirus Epidemiology Donor study
    • Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus Epidemiology Donor study. NEngl J Med, http://dx.doi.org/10.1056/NEJM199606273342601, 1996;334: 1685-1690.
    • (1996) NEngl J Med , vol.334 , pp. 1685-1690
    • Schreiber, G.B.1    Busch, M.P.2    Kleinman, S.H.3    Korelitz, J.J.4
  • 5
    • 34247568569 scopus 로고    scopus 로고
    • Coexistence of autoantibodies and alloantibodies to red cells due to blood transfusion
    • Ahrens N, Pruss A, Kohne A, Kiesewetter H, Salama A. Coexistence of autoantibodies and alloantibodies to red cells due to blood transfusion. Transfusion. http://dx.doi.org/10.1111/j.1537-2995.2007.01194.x 2007; 47:813-816
    • (2007) Transfusion , vol.47 , pp. 813-816
    • Ahrens, N.1    Pruss, A.2    Kohne, A.3    Kiesewetter, H.4    Salama, A.5
  • 7
    • 33748807736 scopus 로고    scopus 로고
    • Survival of medically treated thalassemia patients in Cyprus Trends and risk factorsover the period 1908-2004
    • Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou EK, et al. Survival of medically treated thalassemia patients in Cyprus. Trends and risk factorsover the period 1908-2004. Haematologica 2006;91: 1187-1192
    • (2006) Haematologica , vol.91 , pp. 1187-1192
    • Telfer, P.1    Coen, P.G.2    Christou, S.3    Hadjigavriel, M.4    Kolnakou, A.5    Pangalou, E.K.6
  • 8
    • 0025296108 scopus 로고
    • Antibody to hepatitis C virus in multiply transfused patients with thalassaemiamajor
    • Wonke B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiply transfused patients with thalassaemiamajor.J ClinPatho1990;43: 638-640.
    • (1990) J ClinPatho , vol.43 , pp. 638-640
    • Wonke, B.1    Hoffbrand, A.V.2    Brown, D.3    Dusheiko, G.4
  • 9
    • 0028141421 scopus 로고
    • Antibodies to hepatitis C virus in thalassaemia
    • Angelucci E. Antibodies to hepatitis C virus in thalassaemia.Haematologica1994;79: 353-355.
    • (1994) Haematologica , vol.79 , pp. 353-355
    • Angelucci, E.1
  • 10
    • 0842324888 scopus 로고    scopus 로고
    • Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolyticanemia?
    • Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolyticanemia?.Transfusion, http://dx.doi.org/10.1046/j.0041-1132.2003.00589.x, 2004; 44: 67-72.
    • (2004) Transfusion , vol.44 , pp. 67-72
    • Young, P.P.1    Uzieblo, A.2    Trulock, E.3    Lublin, D.M.4    Goodnough, L.T.5
  • 11
    • 0242440019 scopus 로고    scopus 로고
    • RBC alloimmunization and autoimmunization among transfusion-dependant Arab thalassemia patients
    • Ameen R, Al-Shemmari S, Al-Humood S, ChowdhurryRI,Al-Eyaadi O, Al-Bashir A.RBC alloimmunization and autoimmunization among transfusion-dependant Arab thalassemia patients. Transfusion. http://dx.doi.org/10.1046/j.1537-2995.2003.00549.x 2003;43: 1604-1610
    • (2003) Transfusion , vol.43 , pp. 1604-1610
    • Ameen, R.1    Al-Shemmari, S.2    Al-Humood, S.3    Chowdhurry, R.I.4    Al-Eyaadi, O.5    Al-Bashir, A.6
  • 12
    • 56449083645 scopus 로고    scopus 로고
    • Transfusion medicine in developing country-Alloantibodies to red blood cells in multitransfused patients in Saudi Arabia
    • Gader AMA, Al Ghomlas AK, Al Momen AK. Transfusion medicine in developing country-Alloantibodies to red blood cells in multitransfused patients in Saudi Arabia.Transf. apheresis science2008;39:199-204.
    • (2008) Transf. apheresis science , vol.39 , pp. 199-204
    • Gader, A.M.A.1    Al Ghomlas, A.K.2    Al Momen, A.K.3
  • 14
    • 80053454295 scopus 로고    scopus 로고
    • High frequency ofautoimmunizationamong transfusion-dependent Tunisian thalassemia patients
    • Dhouib N,Mezri M,Hmida H,Mellouli F, Kaabi H, Ouderni M, et al. High frequency ofautoimmunizationamong transfusion-dependent Tunisian thalassemia patients. Transf apheresis 2011;45: 199-20
    • (2011) Transf apheresis , vol.45 , pp. 199-220
    • Dhouib, N.1    Mezri, M.2    Hmida, H.3    Mellouli, F.4    Kaabi, H.5    Ouderni, M.6
  • 16
    • 84877970840 scopus 로고    scopus 로고
    • Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up
    • CappelliniMD,Bejaoui M, Agaoglu L, Canatan D, CapraM,Cohen A, et al.Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood 2011;22:115-120
    • (2011) Blood , vol.22 , pp. 115-120
    • Cappellini, M.D.1    Bejaoui, M.2    Agaoglu, L.3    Canatan, D.4    Capra, M.5    Cohen, A.6
  • 17
    • 77950425913 scopus 로고    scopus 로고
    • Deferasirox pharmacokinetics in patients with adequate versus inadequate response
    • ChimomasD,Smith AL, BrausteinJ,Finkelstein Y, Pereira L, Bergmann AK, et al.Deferasirox pharmacokinetics in patients with adequate versus inadequate response. Blood. http://dx.doi.org/10.1182/blood-2009-05-222729 2009;114:4009-4013
    • (2009) Blood , vol.114 , pp. 4009-4013
    • Chimomas, D.1    Smith, A.L.2    Braustein, J.3    Finkelstein, Y.4    Pereira, L.5    Bergmann, A.K.6
  • 21
    • 33750049951 scopus 로고    scopus 로고
    • Multi-Centre Study of Iron Overload Research Group Increased prevalence of iron-overload associated endocrinopathy in thalassaemiaversus sickle-cell disease
    • Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, et al.: Multi-Centre Study of Iron Overload Research Group.Increased prevalence of iron-overload associated endocrinopathy in thalassaemiaversus sickle-cell disease. Br J Haematol 2006; 135:574-582.
    • (2006) Br J Haematol , vol.135 , pp. 574-582
    • Fung, E.B.1    Harmatz, P.R.2    Lee, P.D.3    Milet, M.4    Bellevue, R.5    Jeng, M.R.6
  • 22
    • 0030848911 scopus 로고    scopus 로고
    • Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia
    • Jensen CE, Tuck SM, Old J, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol. http://dx.doi.org/10.1111/j.1600-0609.1997.tb00729.x 1997;59: 76-81
    • (1997) Eur J Haematol , vol.59 , pp. 76-81
    • Jensen, C.E.1    Tuck, S.M.2    Old, J.3
  • 23
    • 0029063078 scopus 로고
    • Italian Working Group on Endocrine Complications in Nonendocrine Diseases Multicentre study on prevalence of endocrine complications in thalassaemia, major
    • Italian Working Group on Endocrine Complications in Nonendocrine Diseases Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995;42:581-586.
    • (1995) Clin Endocrinol , vol.42 , pp. 581-586
  • 24
  • 25
    • 12544260252 scopus 로고    scopus 로고
    • Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF)
    • De Sanctis V, Eleftheriou A, Malaventura C. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev 2004;2:249-255
    • (2004) Pediatr Endocrinol Rev , vol.2 , pp. 249-255
    • De Sanctis, V.1    Eleftheriou, A.2    Malaventura, C.3
  • 26
    • 0025108768 scopus 로고
    • Treatment of Cooley's anemia
    • Fosburg MT, Nathan D.G. Treatment of Cooley's anemia. Blood 1990;76: 435-444
    • (1990) Blood , vol.76 , pp. 435-444
    • Fosburg, M.T.1    Nathan, D.G.2
  • 27
    • 0035725754 scopus 로고    scopus 로고
    • Risk of Infection and Death Among Post-splenectomy Patients
    • Bisharat N, Omari H, Lavi I. Risk of Infection and Death Among Post-splenectomy Patients. Journal of Infection. http://dx.doi.org/10.1053/jinf.2001.0904 2001;43:182-186
    • (2001) Journal of Infection , vol.43 , pp. 182-186
    • Bisharat, N.1    Omari, H.2    Lavi, I.3
  • 28
    • 0037376609 scopus 로고    scopus 로고
    • Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries
    • Resende V, Petroianu A. Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries. Am Surg2003. http://dx.doi.org/10.1016/S0002-9610(02)01407-1;185:311-315
    • (2003) Am Surg , vol.185 , pp. 311-315
    • Resende, V.1    Petroianu, A.2
  • 29
    • 85047693774 scopus 로고    scopus 로고
    • Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children
    • Rice HE, Oldham KT, Hillery CA, Skinner MA, O'Hara SM,Ware RE. Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children. Ann Surg. http://dx.doi.org/10.1097/01.SLA.0000048453.61168.8F, 2003;237:281-288
    • (2003) Ann Surg , vol.237 , pp. 281-288
    • Rice, H.E.1    Oldham, K.T.2    Hillery, C.A.3    Skinner, M.A.4    O'Hara, S.M.5    Ware, R.E.6
  • 30
  • 31
    • 0025551986 scopus 로고
    • Cardiac disease-free survival in patients with thalassemia major treated with subcutaneous deferoxamine An update of the Toronto cohort
    • Olivieri NF, McGee A, Liu P, Koren G, Freedman MH, Benson L. Cardiac disease-free survival in patients with thalassemia major treated with subcutaneous deferoxamine. An update of the Toronto cohort.Ann NY AcadSci, http://dx.doi.org/10.1111/j.1749-6632.1990.tb24374.x, 1990;612:585-586
    • (1990) Ann NY AcadSci , vol.612 , pp. 585-586
    • Olivieri, N.F.1    McGee, A.2    Liu, P.3    Koren, G.4    Freedman, M.H.5    Benson, L.6
  • 32
    • 29744463847 scopus 로고    scopus 로고
    • Longitudinal study of survival and causes of death in patients with thalassemia major in Greece
    • Ladis V, Chouliaras G, Bedousi H, et al. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y AcadSc i, http://dx.doi.org/10.1196/annals.1345.067, 2005;1054:445-450
    • (2005) Ann N Y AcadSc i , vol.1054 , pp. 445-450
    • Ladis, V.1    Chouliaras, G.2    Bedousi, H.3
  • 34
    • 56049119080 scopus 로고    scopus 로고
    • Prevalence and preventive measures for thalassemia in Hazara region of NWFP Pakistan
    • Buki MK, Qayum I, Siddiqui N. Prevalence and preventive measures for thalassemia in Hazara region of NWFP Pakistan. JAMC 1998; 10: 28-31.
    • (1998) JAMC , vol.10 , pp. 28-31
    • Buki, M.K.1    Qayum, I.2    Siddiqui, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.